Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
CNSP
#4004
CNS Pharmaceuticals, Inc. Common Stock
3.1
6
+4.29%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+4.29%
Aylık değişim
-48.11%
6 aylık değişim
-49.76%
Yıllık değişim
+35.62%
Önceki kapanış
3.0
3
Open
3.1
7
Bid
Ask
Low
3.0
9
High
3.1
7
Hacim
4
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
CNSP
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
28.11
44.48
74.21
354.5
245.37 K
—
Valuation ratios
Enterprise value
—
—
—
—
—
—
Price to earnings ratio
—
—
—
—
—
—
Price to sales ratio
—
—
—
—
—
—
Price to cash flow ratio
—
—
—
—
—
—
Price to book ratio
—
—
—
—
—
—
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
0.6
-1.6
-1.17
-11.08
-1.71
-1.11
Return on equity %
0.68
-2.12
-1.88
4.25
-2.41
-1.41
Return on invested capital %
6 290.05
-4 005
-4 206.49
-11.53 K
-15.3 K
—
Gross margin %
100
—
100
100
100
—
Operating margin %
597.26 K
—
490.75 K
-69.39 K
-7.84 M
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
597.47 K
—
490.97 K
-69.33 K
-7.82 M
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
8.13
3.5
2.55
0.26
3.43
24.41
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
-0
0
0
0
Solvency ratios
Debt to assets ratio
0.06
0.09
0.07
—
—
—
Debt to equity ratio
0.07
0.12
0.11
—
—
—
Long term debt to total assets ratio
0.03
0.04
0.03
0.18
0.04
0.06
Long term debt to total equity ratio
0.03
0.06
0.05
-0.07
0.05
0.08
Per share metrics
Operating cash flow per share
—
—
-232.6 K
-112.6 K
-537.25
-204.35
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
18.94 K
—
—
—
Cash per share
—
—
221.53 K
4 369.53
202.85
310.69
Net current asset value per share
—
—
276.81 K
12.67 K
271.82
390.8
Tangible book value per share
—
—
179.17 K
-35.29 K
193.91
295.38
Working capital per share
—
—
168.41 K
-36.17 K
192.58
292.07
Book value per share
—
—
179.17 K
-35.29 K
193.91
295.38
Haberler
CNS Pharmaceuticals appoints three new executives to leadership team
CNS Pharmaceuticals’ new CEO outlines strategic overhaul
Corero Network Security, Michelle Ragusa-McBain’i kanal şefi olarak atadı
Corero Network Security DDoS koruma platformunda iyileştirmeler bildiriyor
Corero Network Security reports DDoS protection platform enhancements
CNS Pharmaceuticals hisseleri CEO’nun istifasının ardından düştü
CNS Pharmaceuticals stock falls after CEO steps down
CNS Pharmaceuticals, John Climaco’nun yerine Rami Levin’i yeni CEO olarak atadı
CNS Pharmaceuticals appoints Rami Levin as new CEO, replacing Climaco
CNS Pharmaceuticals hissedarları yıllık toplantıda hisse artışını ve yönetim kurulunu onayladı
CNS Pharmaceuticals shareholders approve share increases and board elections at annual meeting
CNS Pharmaceuticals, Inc. (CNSP) Shareholder/Analyst Call Prepared Remarks Transcript